These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 14972084)
1. Pharmacogenetics of antihypertensive drug response. Kreutz R Curr Hypertens Rep; 2004 Feb; 6(1):15-20. PubMed ID: 14972084 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of antihypertensive drug responses. Schwartz GL; Turner ST Am J Pharmacogenomics; 2004; 4(3):151-60. PubMed ID: 15174896 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive pharmacogenetics: getting the right drug into the right patient. Turner ST; Schwartz GL; Chapman AB; Hall WD; Boerwinkle E J Hypertens; 2001 Jan; 19(1):1-11. PubMed ID: 11204288 [TBL] [Abstract][Full Text] [Related]
9. An update on the pharmacogenetics of treating hypertension. Fontana V; Luizon MR; Sandrim VC J Hum Hypertens; 2015 May; 29(5):283-91. PubMed ID: 25355012 [TBL] [Abstract][Full Text] [Related]
10. Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Johnson AD; Newton-Cheh C; Chasman DI; Ehret GB; Johnson T; Rose L; Rice K; Verwoert GC; Launer LJ; Gudnason V; Larson MG; Chakravarti A; Psaty BM; Caulfield M; van Duijn CM; Ridker PM; Munroe PB; Levy D; ; ; Hypertension; 2011 May; 57(5):903-10. PubMed ID: 21444836 [TBL] [Abstract][Full Text] [Related]
11. [Individual sensitivity to antihypertensive drugs: genetic aspects]. Minushkina LO; Zateĭshchikov DA; Sidorenko BA Kardiologiia; 2005; 45(7):58-65. PubMed ID: 16091664 [TBL] [Abstract][Full Text] [Related]
12. The antihypertensive response to irbesartan treatment from a pharmacogenetic perspective. Kurland L Minerva Med; 2003 Aug; 94(4):251-8. PubMed ID: 14605589 [TBL] [Abstract][Full Text] [Related]
13. Human pharmacogenomic variation of antihypertensive drugs: from population genetics to personalized medicine. Polimanti R; Iorio A; Piacentini S; Manfellotto D; Fuciarelli M Pharmacogenomics; 2014 Feb; 15(2):157-67. PubMed ID: 24444406 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs. Hiltunen TP; Donner KM; Sarin AP; Saarela J; Ripatti S; Chapman AB; Gums JG; Gong Y; Cooper-DeHoff RM; Frau F; Glorioso V; Zaninello R; Salvi E; Glorioso N; Boerwinkle E; Turner ST; Johnson JA; Kontula KK J Am Heart Assoc; 2015 Jan; 4(1):e001521. PubMed ID: 25622599 [TBL] [Abstract][Full Text] [Related]
16. Current concepts and molecular mechanisms in pharmacogenetics of essential hypertension. Rahman F; Muthaiah N; Kumaramanickavel G Indian J Pharmacol; 2021; 53(4):301-309. PubMed ID: 34414909 [TBL] [Abstract][Full Text] [Related]
17. Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization Strategies. Loganathan L; Gopinath K; Sankaranarayanan VM; Kukreti R; Rajendran K; Lee JK; Muthusamy K Curr Drug Targets; 2020; 21(1):18-33. PubMed ID: 31393243 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics considerations in the control of hypertension. Lupoli S; Salvi E; Barcella M; Barlassina C Pharmacogenomics; 2015 Nov; 16(17):1951-64. PubMed ID: 26555875 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacogenetics and pharmacogenomics. Searching for individual antihypertensive therapy concepts]. Brand E MMW Fortschr Med; 2003 May; 145(19):43-4. PubMed ID: 12813978 [No Abstract] [Full Text] [Related]